Cytiva

Cytiva, established in 2020 and formerly a division of GE Healthcare Life Sciences, operates as a significant global provider of medical application technologies and services. Its core mission is to advance and accelerate the development of therapeutics, serving the biopharmaceutical industry. Headquartered in Marlborough, Massachusetts, the company leverages its expertise to support critical stages of drug discovery, development, and manufacturing. With a focus on innovation and scientific rigor, Cytiva aims to enable its customers to bring life-saving treatments to patients more efficiently.

The company demonstrates substantial operational scale, reporting an annual revenue of $6.1 billion and employing Over 10,000 employees across its global operations. Cytiva's infrastructure supports a wide array of life science applications, contributing to advancements in areas such as bioprocessing and cell and gene therapy. Interested parties can learn more about the individuals driving these initiatives by visiting Meet Cytiva's team. The company operates in the Medical Devices & Equipment and Manufacturing industries, positioning itself as a key player in the healthcare technology sector.

Cytiva's product and service portfolio is designed to enhance the speed and efficiency of therapeutic development. Its offerings include technologies for biomanufacturing, analytical instruments, and consumables crucial for research and production. By providing integrated solutions, Cytiva empowers researchers and manufacturers to overcome complex challenges in bringing novel therapies to market. Its strategic focus on innovation and customer collaboration solidifies its role in shaping the future of global healthcare.